Formycon AG (FYB) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.011x

Based on the latest financial reports, Formycon AG (FYB) has a cash flow conversion efficiency ratio of 0.011x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€4.54 Million ≈ $5.30 Million USD) by net assets (€399.14 Million ≈ $466.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See FYB defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Formycon AG - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Formycon AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Formycon AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Formycon AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
First Bancorp Inc NASDAQ:FNLC	0.054x
Ascencio (D) BR:ASCE	0.035x
Yuen Foong Yu Consumer Prod TW:6790	0.071x
Sphera Franchise Group SA MiFID Eligible Security RO:SFG	0.689x
BRASI.CIA BRAS.D.PROP.ADR F:52BA	-0.017x
Guangdong Liantai Environmental Protection Co Ltd SHG:603797	0.040x
Hangzhou Huaxing Chuangye Communication Technology Co Ltd SHE:300025	-0.007x
Incar Financial Service Co. Ltd. KQ:211050	0.307x

Annual Cash Flow Conversion Efficiency for Formycon AG (2009–2025)

The table below shows the annual cash flow conversion efficiency of Formycon AG from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see FYB stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€399.14 Million ≈ $466.63 Million	€10.78 Million ≈ $12.61 Million	0.027x	+153.73%
2024-12-31	€461.84 Million ≈ $539.94 Million	€-23.22 Million ≈ $-27.15 Million	-0.050x	-156.68%
2023-12-31	€502.75 Million ≈ $587.77 Million	€-9.85 Million ≈ $-11.51 Million	-0.020x	+63.23%
2022-12-31	€356.58 Million ≈ $416.88 Million	€-18.99 Million ≈ $-22.21 Million	-0.053x	+78.01%
2021-12-31	€55.89 Million ≈ $65.34 Million	€-13.54 Million ≈ $-15.83 Million	-0.242x	-216.50%
2020-12-31	€68.04 Million ≈ $79.54 Million	€-5.21 Million ≈ $-6.09 Million	-0.077x	-145.04%
2019-12-31	€48.21 Million ≈ $56.36 Million	€-1.51 Million ≈ $-1.76 Million	-0.031x	-107.81%
2018-12-31	€33.24 Million ≈ $38.86 Million	€13.30 Million ≈ $15.55 Million	0.400x	+345.01%
2017-12-31	€25.54 Million ≈ $29.86 Million	€-4.17 Million ≈ $-4.88 Million	-0.163x	+32.29%
2016-12-31	€20.89 Million ≈ $24.42 Million	€-5.04 Million ≈ $-5.89 Million	-0.241x	-1260.19%
2015-12-31	€24.87 Million ≈ $29.08 Million	€517.00K ≈ $604.43K	0.021x	+981.57%
2014-12-31	€13.64 Million ≈ $15.95 Million	€-32.17K ≈ $-37.61K	-0.002x	+99.83%
2013-12-31	€12.25 Million ≈ $14.32 Million	€-16.65 Million ≈ $-19.47 Million	-1.359x	-368.19%
2012-12-31	€4.26 Million ≈ $4.98 Million	€2.16 Million ≈ $2.52 Million	0.507x	+6644.70%
2011-12-31	€5.14 Million ≈ $6.01 Million	€38.60K ≈ $45.13K	0.008x	+101.07%
2010-12-31	€4.07 Million ≈ $4.76 Million	€-2.85 Million ≈ $-3.33 Million	-0.700x	+8.21%
2009-12-31	€640.00K ≈ $748.23K	€-487.93K ≈ $-570.44K	-0.762x	--

About Formycon AG

XETRA:FYB Germany Biotechnology

Market Cap

$404.97 Million

€346.39 Million EUR

Market Cap Rank

#14372 Global

#1439 in Germany

Share Price

€19.60

Change (1 day)

-1.71%

52-Week Range

€16.82 - €30.60

All Time High

€92.50